RIVA, AGOSTINO
RIVA, AGOSTINO
Dipartimento di Scienze Biomediche e Cliniche
Longitudinal multi-omic dynamics in hospitalized COVID-19 patients based on disease severity
2026 C.M. Basting, T.A. Schroeder, R. Shields-Cutler, E. Swanson, C. Guerrero, C.R. Hemmila, C.A. Broedlow, A. Chakrawarti, A. Velez, R. Cromarty, A. Riva, A. Torre, A. Lai, L. Schifanella, N.R. Klatt
SARS-CoV-2 intra-host evolution during acute infection in COVID-19 patients
2026 C. Della Ventura, A. Bergna, C.L. Ciubotariu, M. Liturri, C. Conflitti, M. Corbellino, S. Antinori, A. Riva, G. Zehender, A. Lai
Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV on Any Antiretroviral Therapy Regimen: The Retrospective ESSENTIAL Study
2026 M.V. Cossu, D. Moschese, M. Matone, L. Oreni, G. Carrozzo, A. Poloni, G. Pozza, L. Albini, G. Forcina, C. Gervasoni, A. Riva, A. Giacomelli, A. Gori
Breaking barriers in extensively drug-resistant TB: pretomanid-centred long regimen achieves cure in a bedaquiline-resistant strain
2026 M. Schiuma, A. Piubello, F. Saluzzo, D. Cattaneo, F. Salari, A. Covizzi, A. Rizzo, F. Fama, C. Ciubotariu, A. Lombardi, S. Antinori, A. Riva, D.M. Cirillo, A. Gori, A. Torre
Learning from post-COVID-19 condition for epidemic preparedness: a variable catalogue for future post-acute infection syndromes
2025 A. Górska, L.M. Canziani, E. Rinaldi, Z.D. Pana, S. Beale, F. Bai, B.M. Boxma-de Klerk, S. de Bruijn, D. Donà, M.B. Ekkelenkamp, F. Incardona, P. Mallon, G.C. Marchetti, M. Puhan, A. Riva, V.C. Simensen, M. Vaillant, M.M. van der Zalm, S.M.J. van Kuijk, S.V. Wingerden, A. Judd, E. Tacconelli, J.L. Peñalvo
Genomic Epidemiology of the Main SARS‐CoV‐2 Variants Circulating in Italy During the Omicron Era
2025 A. Bergna, A. Lai, F. Sagradi, S. Menzo, N. Mancini, B. Bruzzone, S. Rusconi, G. Marchegiani, N. Clementi, D. Francisci, I. Vicenti, S. Ronchiadin, H.D. Mbissam, C. Della Ventura, L. Lanfranchi, S. Testa, S. Caucci, C. Acciarri, L. Carioti, A. Occhionero, F. Novazzi, A.P. Genoni, F.D. Ferrante, V. De Pace, M. Ferraris, M. Ogliastro, A. Gabrieli, M. De Paschale, G. Canavesi, M.C. Bellocchi, M. Iannetta, L. Sarmati, F. Ceccherini‐silberstein, A. Riva, S. Antinori, G. Zehender, N. Null
Early results from implementation of HIV pre-exposure prophylaxis (PrEP) with long-acting injectable cabotegravir for people with barriers to oral strategies, Italy, December 2024 to August 2025
2025 D. Moschese, R. Esvan, C. Fusetti, V. Barchi, M.V. Cossu, A. Giacinta, S. Lazzarin, G. Terracini, F. Caruso, G. Micheli, D. Maddalena, G. Del Duca, F. Petri, G. Frate, M. Matone, D. Farinacci, A. Giacomelli, P. Faccendini, D. Visigalli, S. Passacantilli, A. Riva, A. Antinori, A. Gori, V. Mazzotta
NAT2 Acetylation Status Predicts Hepatotoxicity During Antituberculosis Therapy: Cumulative Risk Analysis of a Multiethnic Cohort
2025 M. Schiuma, S. Dinegro, V. Battini, A. Torre, A. Covizzi, A. Civati, M. Galimberti, I. Mariani, G. Mosini, C. Carnovale, A. Riva, A. Gori, S. Antinori, E. Clementi, S. Radice, S. Cheli
Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab
2025 L. Moiola, A. Mandelli, M. Tarkowski, A. Finardi, A. Gabrieli, C. Zanetta, V. Viti, I. Gattuso, F. Esposito, R. Pedotti, E. Muros-Le Rouzic, C. Raposo, M.A. Rocca, M. Locatelli, C. Bonini, R. Furlan, A. Riva, M. Filippi
High effectiveness of ceftriaxone monotherapy and limited value of routine test-of-cure for Gonorrhoea in a low-resistance setting
2025 C. Fusetti, F. Salari, F. Petri, A. Rizzo, A. Giacomelli, A. Cavallo, F. Caruso, L. Morelli, C. Gervasoni, D. Mileto, M. Vittoria Cossu, A. Lombardi, A. Riva, A. Gori, D. Moschese
A 40 colors spectral panel to decipher human NK cell involvement in the establishment of NeuroCOVID-19
2025 A. Frigo, C. DI VITO, F. Calcaterra, F. Masserini, A. Carletti, A. Nicotra, E. Perdixi, C. Gallo, P. Emiliano Doneddu, A. Forgione, S. Pomati, F. Terenghi, E. Nobile-Orazio, A. Riva, L. Pantoni, D. Mavilio
Rifampicin drug monitoring in TB patients: new evidence for increased dosage?
2025 M. Schiuma, M. Colaneri, D. Cattaneo, M. Fusi, A. Civati, M. Galimberti, M.V. Cossu, C. Gervasoni, A. Dolci, A. Riva, S. Antinori, A. Gori, A. Torre
Unilateral uveitis following adjuvanted Varicella-Zoster subunit vaccine in a patient with previously resolved Varicella Zoster acute retinal necrosis
2025 A. Trinco, F. Zicarelli, F. Romano, M. Oldani, A. Riva, A. Invernizzi
Operationalisation of post-COVID condition case definition in a comprehensive research protocol
2025 F. Masserini, A. Nicotra, A. Forgione, F. Calcaterra, E. Perdixi, C. Di Vito, A. Carletti, C. Gallo, P.E. Doneddu, F. Terenghi, S. Pomati, E. Nobile-Orazio, A. Riva, D. Mavilio, L. Pantoni
Evolution of causes of death in People with HIV between 2000 and 2023: a single center retrospective Study
2025 G. Carrozzo, G. Pozza, A. Poloni, S. Caronni, M.V. Cossu, D. Moschese, M. Matone, C. Gervasoni, A.L. Ridolfo, L. Oreni, A. Riva, S. Antinori, A. Gori, A. Giacomelli
Potential use of the SARS-CoV-2 monoclonal antibody sipavibart in people with multiple sclerosis: definition of different patient archetypes from an Italian expert group perspective
2025 C. Zanetta, C. Gasperini, M.P. Amato, D. Centonze, P. Gallo, F. Patti, A. Riva, M. Filippi
Impact of Early Antiviral Therapy on SARS-CoV-2 Clearance Time in High-Risk COVID-19 subjects: A Propensity Score Matching Study
2024 M. Colaneri, F. Fama, F. Fassio, D. Holmes, G. Scaglione, C. Mariani, L. Galli, A. Lai, S. Antinori, A. Gori, A. Riva, M. Schiavini
Host genetics and COVID-19 severity: increasing the accuracy of latest severity scores by Boolean quantum features
2024 M. Gabriele, T. Alessio, F. Chiara, D. Andrea, B. Margherita, O. Simona, F. Simone, R. Alessandra, A. Riva
Hospital-Based Influenza and Pneumococcal Vaccination for Cancer Patients on Active Treatment and Their Family Members during the COVID-19 Pandemic in Italy: A Single-Center Experience
2024 D. Dalu, A.L. Ridolfo, L. Ruggieri, M.S. Cona, A. Riva, D. De Francesco, C. Tricella, C. Fasola, S. Ferrario, A. Gambaro, B. Lombardi Stocchetti, V. Smiroldo, G. Rebecchi, S. Piva, G. Carrozzo, S. Antinori, N. La Verde
Modulation of CCR5 expression and R5 HIV-1 infection in primary macrophages exposed to sera from HESN, LTNP, and chronically HIV-1 infected people with or without natural antibodies to CCR5
2024 I. Farina, M. Andreotti, C. Pastori, R. Bona, C.M. Galluzzo, R. Amici, C. Purificato, C. Uberti-Foppa, A. Riva, M.C. Gauzzi, L. Lopalco, L. Fantuzzi